Briefs

Search Briefs


Alerts

Sign up for Health Policy Brief Alerts




Recent Health Policy Briefs

Veterans Health Administration

The Veterans Health Administration can often obtain very favorable prices for drugs and may be a model for Medicare and others.  AUGUST 10, 2017
Read and Save Printable PDF >>


Medicaid Best Price

The Medicaid best price policy requires drug manufacturers to give Medicaid programs the best price among nearly all purchasers.  AUGUST 10, 2017
Read and Save Printable PDF >>


Medicare Part D

Medicare Part D covers retail prescription drugs for Medicare beneficiaries through unique, stand-alone drug insurance plans.  AUGUST 10, 2017
Read and Save Printable PDF >>


Medicare Part B

The Medicare Part B "buy and bill" payment structure for physician-administered drugs also influences private-sector prices.  AUGUST 10, 2017
Read and Save Printable PDF >>


Patent Settlements

The timing of a generic drug's market entry may be determined by "pay for delay" patent settlements between drug companies.  JULY 21, 2017
Read and Save Printable PDF >>


Biosimilars

Follow-on products to innovative brand-name biologic medicines may lower overall drug spending by creating price competition.  JULY 21, 2017
Read and Save Printable PDF >>


Pricing Orphan Drugs

A 1983 law created incentives to develop drugs to treat rare diseases that might otherwise not justify commercial investment.  JULY 21, 2017
Read and Save Printable PDF >>


Expedited Approval Pathways

For drugs of particular clinical importance, the Food and Drug Administration offers several expedited development and approval pathways.  JULY 21, 2017
Read and Save Printable PDF >>